Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Tangedal, Solveig ^a   Aanerud, Marianne ^a   Persson, Louise JP ^a   Brokstad, Karl A ^b   Bakke, Per S ^b   Eagan, Tomas M ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

COPD; Inflammatory markers; Sputum sampling

Indexed keywords

ALBUMIN; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOASSAY; INFLAMMATION; MALE; SAMPLING; SPUTUM ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY; SPUTUM; TIME FACTOR;

AGED; BIOMARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SPUTUM; TIME FACTORS;

EID: 84920847598     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-014-0138-6     Document Type: Article

References (32)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. [], [ http://www.goldcopd.com/guidelines-global-strategy-for-diagnosis-management.html ]
2. Brusasco V, Crimi E, Pellegrino R: Airway inflammation in COPD: friend or foe?. Am J Respir Crit Care Med. 2007, 176: 425-426. 10.1164/rccm.200706-820ED.
3. Warwick G, Thomas PS, Yates DH: Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology. 2013, 18: 874-884. 10.1111/resp.12089.
4. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, Sterk PJ: Sputum induction. Eur Respir J Suppl. 2002, 37: 3s-8s.
5. Dragonieri S, Tongoussouva O, Zanini A, Imperatori A, Spanevello A: Markers of airway inflammation in pulmonary diseases assessed by induced sputum. Monaldi Arch Chest Dis. 2009, 71: 119-126.
6. Wark PA, Simpson JL, Hensley MJ, Gibson PG: Safety of sputum induction with isotonic saline in adults with acute severe asthma. Clin Exp Allergy. 2001, 31: 1745-1753. 10.1046/j.1365-2222.2001.01230.x.
7. Gao P, Gibson PG, Zhang J, He X, Hao Y, Li P, Liu H: The safety of sputum induction in adults with acute exacerbation of COPD. Clin Respir J. 2013, 7: 101-109. 10.1111/j.1752-699X.2012.00291.x.
8. Tsoumakidou M, Tzanakis N, Siafakas NM: Induced sputum in the investigation of airway inflammation of COPD. Respir Med. 2003, 97: 863-871. 10.1016/S0954-6111(03)00035-0.
9. Makris D, Tzanakis N, Moschandreas J, Siafakas NM: Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med. 2006, 6: 17-10.1186/1471-2466-6-17.
10. Taube C, Holz O, Mucke M, Jorres RA, Magnussen H: Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 1810-1815. 10.1164/ajrccm.164.10.2104024.
11. Bathoorn E, Liesker J, Postma D, Koeter G, van Oosterhout AJ, Kerstjens HA: Safety of sputum induction during exacerbations of COPD. Chest. 2007, 131: 432-438. 10.1378/chest.06-2216.
12. Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, Mistry V, Reid C, Parker D, Dodson P, Jenkins M, Lloyd A, Rugman P, Newbold P, Brightling CE: Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration. 2012, 83: 36-44. 10.1159/000330667.
13. Wallace J, D'Silva L, Brannan J, Hargreave FE, Kanaroglou P, Nair P: Association between proximity to major roads and sputum cell counts. Can Respir J. 2011, 18: 13-18.
14. Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G: Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax. 1996, 51: 1000-1004. 10.1136/thx.51.10.1000.
15. Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, Dolovich J, Hargreave FE: Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996, 154: 866-869. 10.1164/ajrccm.154.4.8887576.
16. Bhowmik A, Seemungal TA, Sapsford RJ, Devalia JL, Wedzicha JA: Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax. 1998, 53: 953-956. 10.1136/thx.53.11.953.
17. Koutsokera A, Kostikas K, Nicod LP, Fitting JW: Pulmonary biomarkers in COPD exacerbations: a systematic review. Respir Res. 2013, 14: 111-10.1186/1465-9921-14-111.
18. Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damas JK, Aukrust P, Bakke PS: Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010, 35: 540-548. 10.1183/09031936.00088209.
19. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 161: 1608-1613. 10.1164/ajrccm.161.5.9908022.
20. Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MM, Pizzichini E, Ronchi C, Van Overvel F, Djukanovic R: Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl. 2002, 37: 19s-23s.
21. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310. 10.1016/S0140-6736(86)90837-8.
22. Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res. 1999, 8: 135-160. 10.1191/096228099673819272.
23. Woolhouse IS, Bayley DL, Stockley RA: Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax. 2002, 57: 667-671. 10.1136/thorax.57.8.667.
24. Holz O, Jorres RA, Koschyk S, Speckin P, Welker L, Magnussen H: Changes in sputum composition during sputum induction in healthy and asthmatic subjects. Clin Exp Allergy. 1998, 28: 284-292. 10.1046/j.1365-2222.1998.00243.x.
25. Gershman NH, Liu H, Wong HH, Liu JT, Fahy JV: Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol. 1999, 104: 322-328. 10.1016/S0091-6749(99)70374-X.
26. Rackley CR, Stripp BR: Building and maintaining the epithelium of the lung. J Clin Invest. 2012, 122: 2724-2730. 10.1172/JCI60519.
27. Moodley YP, Krishnan V, Lalloo UG: Neutrophils in induced sputum arise from central airways. Eur Respir J. 2000, 15: 36-40. 10.1183/09031936.00.15103600.
28. O'Donnell R, Breen D, Wilson S, Djukanovic R: Inflammatory cells in the airways in COPD. Thorax. 2006, 61: 448-454. 10.1136/thx.2004.024463.
29. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB: Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011, 6: e16384-10.1371/journal.pone.0016384.
30. Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, Wedzicha JA: Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007, 29: 527-534. 10.1183/09031936.00092506.
31. Kersul AL, Iglesias A, Rios A, Noguera A, Forteza A, Serra E, Agusti A, Cosio BG: Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol. 2011, 47: 176-183. 10.1016/j.arbres.2010.12.003.
32. Pizzichini E, Pizzichini MM, Leigh R, Djukanovic R, Sterk PJ: Safety of sputum induction. Eur Respir J Suppl. 2002, 37: 9s-18s.